Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study

por Cullum, Christopher Kjaer, Chaudhry, Basit Ali, Do, Thien Phu, Amin, Faisal Mohammad
Publicado 2023

Use of Non-pharmacological Therapies in Individuals With Migraine Eligible for Treatment With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Signaling: A Si...

por Rundblad, Lucas, Cullum, Christopher Kjaer, Sacco, Simona, Gil-Gouveia, Raquel, Uludüz, Derya, Do, Thien Phu, Amin, Faisal Mohammad
Publicado 2022

The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics

por Karlsson, William Kristian, Ashina, Håkan, Cullum, Christopher Kjær, Christensen, Rune Häckert, Al-Khazali, Haidar Muhsen, Amin, Faisal Mohammad, Ashina, Messoud
Publicado 2023

Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study

por Cullum, Christopher Kjaer, Do, Thien Phu, Ashina, Messoud, Bendtsen, Lars, Hugger, Sarah Sonja, Iljazi, Afrim, Gusatovic, Julia, Snellman, Josefin, Lopez-Lopez, Cristina, Ashina, Håkan, Amin, Faisal Mohammad
Publicado 2022